ESSA Pharma
EPIX
EPIX was delisted on the 8th of October, 2025.
10 hedge funds and large institutions have $1.9M invested in ESSA Pharma in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.52% less ownership
Funds ownership: 1.7% → 1.18% (-0.52%)
9% less funds holding
Funds holding: 11 → 10 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
64% less capital invested
Capital invested by funds: $5.24M → $1.9M (-$3.35M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$70.1K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$15.5K |
| 3 |
VF
Virtu Financial
New York
|
+$9.99K |
| 4 |
Morgan Stanley
New York
|
+$4.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$792K |
| 2 |
DM
Deerfield Management
New York
|
-$779K |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$242K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$112 |
EPIX Hedge Fund Activity: Q3 2017 in Review
10 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in ESSA Pharma (EPIX) for Q3 2017, worth a combined $1.9M — down 64% from $5.24M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of EPIX and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was CIBC World Market, opening a new position worth an estimated $70.1K. The largest seller was AWM Investment Company, exiting entirely with an estimated $792K sold.
- 10 institutional investors held ESSA Pharma (EPIX) as of Q3 2017, down from 11 in Q2 2017.
- Funds reported $1.9M of ESSA Pharma stock for Q3 2017, down 64% quarter-over-quarter.
- 3 funds opened new ESSA Pharma positions in Q3 2017 and 4 closed out, a net change of -1 holder.
- The largest ESSA Pharma buyer in Q3 2017 was CIBC World Market, an estimated $70.1K added.
- The largest ESSA Pharma seller in Q3 2017 was AWM Investment Company, an estimated $792K sold.
Based on aggregated 13F filings for Q3 2017.